We have observed
1 EP application
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 20, 2014).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
COMPOSITION AND METHOD FOR TREATING NUCLEIC ACID-RELATED EYE DISEASE